Loading...
•
Jan 03
Leidos Q4 2024 Earnings Report
Key Takeaways
Leidos reported strong Q4 FY24 results, with revenue increasing 10% year-over-year to $4.37 billion and net income rising 23% to $282 million. Adjusted EPS reached $2.37, a 19% increase from Q4 FY23, driven by growth in managed health services and improved program execution. Operating income stood at $421 million, and free cash flow was $213 million.
Leidos
Leidos
Leidos Revenue by Segment
Revenue by Segment
Health & Civil Revenue
CapyFin.comCommercial & International Revenue
CapyFin.comDefense Systems Revenue
CapyFin.com Forward Guidance
Leidos expects continued revenue and earnings growth in FY25, driven by strong demand in key segments and operational efficiencies.
Positive Outlook
- Revenue projected between $16.9B - $17.3B.
- Non-GAAP diluted EPS expected between $10.35 - $10.75.
- Adjusted EBITDA margin forecasted in mid-to-high 12%.
- Strong backlog of $43.6B supports future revenue visibility.
- Expected cash flows from operations around $1.45B.
Challenges Ahead
- Potential headwinds from macroeconomic uncertainties.
- Continued cost pressures in fixed-price programs.
- Challenges in the security products business mix.
- Expected impact from contract rebaselining in UK operations.
- Increased investments in growth affecting near-term margins.
Revenue & Expenses
Visualization of income flow from segment revenue to net income